BDRL has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
BDRL has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Blonder Tongue Laboratories's net interest income for the three months ended in Jun. 2024 was $-0.21 Mil. Its net interest income for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.85 Mil.
The historical data trend for Blonder Tongue Laboratories's Net Interest Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Blonder Tongue Laboratories Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Net Interest Income | Get a 7-Day Free Trial | -0.26 | -0.35 | -0.51 | -0.79 | -0.87 |
Blonder Tongue Laboratories Quarterly Data | ||||||||||||||||||||
Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | |
Net Interest Income | Get a 7-Day Free Trial | -0.21 | -0.21 | -0.22 | -0.21 | -0.21 |
Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.
Net Interest Income for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.85 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Blonder Tongue Laboratories's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Williams James H /nj/ | director | C/O BLONDER TONGUE LABORATORIES INC, ONE JAKE BROWN RD, OLD BRIDGE NJ 08857 |
Palle Robert J Jr | director, 10 percent owner, officer: President and COO | C/O BLONDER TONGUE LABORATORIES INC, ONE JAKE BROWN ROAD, OLD BRIDGE NJ 08857 |
Eric S Skolnik | officer: Senior Vice President - CFO | C/O BLONDER TONGUE LABORATORIES INC, ONE JAKE BROWN ROAD, OLD BRIDGE NJ 08857 |
John E Burke | director | 1540 BARDSEY LANE, LOWER GWYNEDD PA 19002 |
Anthony J Bruno | director | C/O BLONDER TONGUE LABORATORIES, INC., ONE JAKE BROWN ROAD, OLD BRIDGE NJ 08857 |
Cavalry Fund I Lp | 10 percent owner | 82 EAST ALLENDALE ROAD, SUITE 5B, SADDLE RIVER NJ 07458 |
Michael Hawkey | director | 2160 GOLD STREET, SAN JOSE CA 95002 |
Rick E Briggs | director | C/O BLONDER TONGUE LABORATORIES, INC., ONE JAKE BROWN ROAD, OLD BRIDGE NJ 08857 |
Edward Rowland Grauch | officer: CEO & President | 3208 HIGHWAY 98, MEXICO BEACH FL 32456 |
Jeffrey W Smith | officer: Vice President - Sales | C/O BLONDER TONGUE LABORATORIES, INC., ONE JAKE BROWN ROAD, OLD BRIDGE NJ 08857 |
Ronald Vincent Alterio | officer: VP-Engineering, CTO | C/O BLONDER TONGUE LABORATORIES, ONE JAKE BROWN ROAD, OLD BRIDGE NJ 08857 |
Gary P Scharmett | director | |
Steven L Shea | director | C/O BLONDER TONGUE LABORATORIES, INC., ONE JAKE BROWN ROAD, OLD BRIDGE NJ 08857 |
Stephen K Necessary | director | |
Bruce A Gureck | officer: Exec VP/COO | 4671 BOCAIRE BLVD, BOCA RATON FL 33487 |
From GuruFocus
By GuruFocus Research • 02-12-2024
By GuruFocus Research • 02-12-2024
By GuruFocus Research • 02-12-2024
By ACCESSWIRE ACCESSWIRE • 11-04-2022
By GuruFocus Research • 02-12-2024
By ACCESSWIRE ACCESSWIRE • 06-08-2022
By GuruFocus Research • 02-12-2024
By GuruFocus Research • 02-12-2024
By GuruFocus Research • 02-12-2024
By ACCESSWIRE • 11-06-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.